This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Kura Oncology, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Chaoyi Deng
Introduction
Chaoyi Deng is a notable inventor based in Pudong, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on MENIN inhibitors. His research and inventions have the potential to impact the treatment of various diseases.
Latest Patents
Chaoyi Deng holds a patent for pharmaceutical compositions comprising a MENIN inhibitor. The patent describes crystalline forms of (S)-4-methyl-5-((4-((2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)methyl)-1-(2-(4-(methylsulfonyl)piperazin-1-yl)propyl)-1H-indole-2-carbonitrile or solvate thereof, methods of making such forms, and pharmaceutical compositions comprising such forms. This patent highlights his expertise in developing advanced pharmaceutical solutions.
Career Highlights
Chaoyi Deng is currently associated with Kura Oncology, Inc., where he continues to advance his research in oncology and drug development. His work at Kura Oncology has positioned him as a key player in the pharmaceutical industry, focusing on innovative treatments for cancer.
Collaborations
Chaoyi has collaborated with esteemed colleagues such as Dipanjan Sengupta and Patricia Andres. These collaborations have fostered a productive environment for innovation and research, contributing to the advancement of their shared goals in the pharmaceutical field.
Conclusion
Chaoyi Deng's contributions to the field of pharmaceuticals through his innovative patents and collaborations underscore his importance as an inventor. His work continues to pave the way for new treatments and advancements in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
